Skip to main content

Table 3 RT-3DE parameters in HCM patients versus control group

From: Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging

 

HCM patients (N = 50)

Control group (N = 40)

p value

LVEDV(ml)

70.12 ± 13.91

85.59 ± 14.94

< 0.001

LVESV (ml)

31.09 ± 6.02

29.46 ± 5.47

0.187

LVSV (ml)

39.94 ± 10.67

56.25 ± 11.68

< 0.001

LVEF(%)

57.17 ± 4.15

65.13 ± 2.95

< 0.001

  1. LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, LVSV left ventricular stroke volume, LVEF left ventricular ejection fraction. Values are expressed as the mean ± SD